Related Experiment Video
Updated: Mar 24, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Cancer prevention in HIV-infected populations
Priscila H Goncalves1, Jairo M Montezuma-Rusca2, Robert Yarchoan1
1HIV & AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Abstract:
People living with human immunodeficiency virus (HIV) are living longer since the advent of effective combined antiretroviral therapy (cART). While cART substantially decreases the risk of developing some cancers, HIV-infected individuals remain at high risk for Kaposi sarcoma, lymphoma, and several solid tumors. Currently HIV-infected patients represent an aging group, and malignancies have become a leading cause of morbidity and mortality. Tailored cancer-prevention strategies are needed for this population. In this review we describe the etiologic agents and pathogenesis of common malignancies in the setting of HIV, as well as current evidence for cancer prevention strategies and screening programs.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Retrovirus Life Cycles
Sexually Transmitted Infections
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers

